Kelun-Biotech

Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical, is a clinical-stage biotech company engaged in biologic therapeutics as well as small molecule discovery and development.

lung
Favicon Fierce Pharma

ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS

Combining the TROP2 ADC with Keytruda cut the risk of progression or death by 65% versus Keytruda alone in first-line, PD-L1-positive NSCLC.
Angus Liu May 21, 2026 5:00pm
graphic image of different colored hands shaking

Crescent inks $80M Kelun deal, adding ADC to mix with bispecific

Dec 4, 2025 9:50am
Blue race track
Favicon Fierce Pharma

Merck grows more ambitious about 'workhorse' TROP2 ADC

Oct 20, 2025 4:00pm
windmill turbines in the Netherlands

Windward generates $200M with Novo Holdings, OrbiMed in tow

Jan 10, 2025 10:02am
change direction new plan alter arrows move reprioritize

Merck bags one Kelun ADC for $37.5M, boots out another asset

Aug 20, 2024 6:43am
Merck

Merck trims mushrooming ADC pipeline by axing 2 Kelun programs

Oct 23, 2023 9:00am